Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118475) titled 'Multiparametric MRI Radiomics for Predicting Malignant Risk in Meningiomas' on Feb. 6.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The Second Affiliated Hospital of Hainan Medical University
Condition:
meningioma
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-02-10
Target Sample Size: Observation group:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=307068
Disclaimer: Curated by HT Syndication....